Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a non-content site release.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.2 was added and the previous downtime notice (Revision: v3.4.1) was removed.SummaryDifference0.4%

- Check90 days agoChange DetectedAdded a government funding/status notice and updated the page version to Revision 3.4.1, replacing 3.4.0.SummaryDifference0.4%

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.